News

Ophthalmology Times7h
Q&A: David S. Boyer, MD, on the suprachordial delivery of gene therapy
Boyer discusses a potential treatment for diabetic retinopathy and macular degeneration using suprachoroidal injections, ...
Ophthalmology Times9h
ViGeneron rebrands as VeonGen Therapeutics, announces rare pediatric disease designation for VG801
VG801 is a dual AAV gene therapy that leverages mRNA trans-splicing via the vgRNA REVeRT and vgAAV platforms to deliver the ...